Chronic obstructive pulmonary disease (COPD) has a high prevalence and a major impact
on health-related quality of life (HRQL). COPD exacerbations are an important cause of …

This cross-sectional geospatial analysis explores the prevalence of Chronic Obstructive
Pulmonary Disease (COPD) concerning the proximity to toxic release inventory (TRI) …

Background COVID-19 is primarily known as a respiratory illness; however, many patients
present to hospital without respiratory symptoms. The association between non-respiratory …

Radon decay products include α-radiation emitting radionuclides that attach to airborne
particles that have potential to promote oxidative tissue damage after inhalation. To assess …

Prior research indicates that subjective cognitive decline (SCD) affects approximately one-
third of older adults with Chronic Obstructive Pulmonary Disease (COPD). However, there is …

As the global population ages, pulmonary diseases among older people have emerged as a
significant and growing public health concern. The increasing incidence of these conditions …

Objectives To assess the effects of an exercise training program combining power-oriented
resistance training (RT) and high-intensity interval training (HIIT) on metabolic syndrome …

Background: Fexuprazan (Fexuclue®; Daewoong Pharmaceutical Co., Ltd., Seoul, Korea) is
a novel potassium-competitive acid blocker (P-CAB). This multi-center, randomized, double …

Background: Low socioeconomic status (SES) has been associated with worse clinical
outcomes in chronic obstructive pulmonary disease (COPD). Food insecurity is more …

Background Type 2 diabetes mellitus (T2DM) is a common comorbidity in patients with
chronic obstructive pulmonary disease (COPD) and has been associated with an increased …